Can you provide the upcoming earnings date for AVANOS MEDICAL INC?
AVANOS MEDICAL INC (AVNS) will report earnings on 2026-05-04.
AVANOS MEDICAL INC (AVNS) Forecast, Price Target & Analyst Ratings
NYSE:AVNS • US05350V1061
Current stock price
24.7 USD
-0.01 (-0.04%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for AVANOS MEDICAL INC (AVNS).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- May 4, 2026
- Period
- Q1 / 2026
- EPS Estimate
- $0.14
- Revenue Estimate
- 173.4M
Price Target Details & History
Consensus Price Target and Range
Mean target
N/A
Upside
N/A
From current price of $24.70 to mean target of N/A, Based on 6 analyst forecasts
Low
N/A
Median
N/A
High
N/A
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
43.33%
AVNS was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about AVNS.
In the previous month the buy percentage consensus was at a similar level.
AVNS was analyzed by 6 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2024-05-07 | JMP Securities | Reiterate | Market Perform |
| 2023-07-25 | Keybanc | Downgrade | Overweight -> Sector Weight |
| 2023-06-21 | Stifel | Reiterate | Hold -> Hold |
| 2023-05-22 | CL King | Initiate | Buy |
| 2023-05-04 | Morgan Stanley | Maintains | Underweight |
| 2023-02-22 | Morgan Stanley | Maintains | Underweight |
| 2023-01-06 | Morgan Stanley | Maintains | Underweight |
| 2022-11-03 | Keybanc | Maintains | Overweight |
| 2022-10-11 | Morgan Stanley | Maintains | Underweight |
| 2022-08-10 | Keybanc | Maintains | Overweight |
| 2022-07-18 | Stifel | Maintains | Hold |
| 2022-07-15 | Morgan Stanley | Maintains | Underweight |
| 2022-05-05 | Morgan Stanley | Maintains | Underweight |
| 2022-02-24 | Keybanc | Maintains | Overweight |
| 2022-01-07 | Morgan Stanley | Maintains | Underweight |
| 2021-08-04 | Keybanc | Maintains | Overweight |
| 2021-08-04 | Stephens & Co. | Downgrade | Overweight -> Equal-Weight |
| 2021-08-04 | Morgan Stanley | Maintains | Underweight |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- May 4, 2026
- Period
- Q1 / 2026
- EPS Estimate
- $0.14
- Revenue Estimate
- 173.4M
- Revenue Q2Q
- 3.52%
- EPS Q2Q
- -45.08%
- Number of Analysts
- 3
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
0.29%
EPS (1 Month)
0.00%
EPS (3 Months)
-39.13%
Next Earnings Summary
AVNS is expected to report earnings on 5/4/2026. The consensus EPS estimate for the next earnings is 0.14 USD and the consensus revenue estimate is 173.40M USD.
The next earnings revenue estimate has been revised upward by 0.29% in the past 3 months.
Full Analyst Estimates 2026 - 2027
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 673.3M -17.89% | 687.8M 2.15% | 701.2M 1.95% | 724.2M 3.28% | 754.8M 4.23% | |
| EBITDA YoY % growth | 53.6M -56.67% | 90.2M 68.28% | 55.8M -38.14% | 166.97M 199.23% | 182.58M 9.35% | |
| EBIT YoY % growth | 7.5M -90.13% | 44.7M 496.00% | 16.9M -62.19% | 69.36M 310.41% | 85.068M 22.65% | |
| Operating Margin | 1.11% | 6.50% | 2.41% | 9.58% | 11.27% | |
| EPS YoY % growth | 1.38 -16.36% | 1.26 -8.70% | 0.94 -25.40% | 1.02 8.62% | 1.28 24.98% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.14 -45.08% | 0.17 -2.20% | 0.33 51.15% | 0.38 29.43% | 0.29 105.71% | 0.31 86.50% | 0.33 -2.15% | 0.34 -8.42% |
| Revenue Q2Q % growth | 173.4M 3.52% | 176.46M 0.83% | 184.11M 3.55% | 189.72M 4.88% | 179.83M 3.71% | 184.11M 4.34% | 192.27M 4.43% | 198.08M 4.41% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 10.302M 0.02% | 11.526M 361.04% | 22.338M 22,238.00% | 25.092M 527.30% | N/A | N/A | N/A | N/A |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
AVANOS MEDICAL INC / AVNS Forecast FAQ
What are the consensus estimates for AVNS stock next earnings?
The consensus EPS estimate for the next earnings of AVANOS MEDICAL INC (AVNS) is 0.14 USD and the consensus revenue estimate is 173.40M USD.
Can you provide the analyst count for AVANOS MEDICAL INC stock?
The number of analysts covering AVANOS MEDICAL INC (AVNS) is 6.